What To Watch. Venus Remedies board meets for pref issue

Shares of Venus Remedies will remain in focus, as its board of directors will meet on Tuesday to consider issuing fully convertible warrants/ equity shares to promoters on preferential basis. The allotment is, however, subject to approval in the general meeting. It reported a loss of ₹20.66 crore for the quarter ended March 2015 as against a net profit of ₹14.11 crore in the same period previous year. Net sales also declined 28 per cent to ₹98.88 crore (₹142.32 crore).